Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 135

    1.

    Progression to islet destruction in a cyclophosphamide-induced transgenic model: a microarray overview.

    Matos M, Park R, Mathis D, Benoist C.

    Diabetes. 2004 Sep;53(9):2310-21.PMID: 15331540 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Disease resistant, NOD-related strains reveal checkpoints of immunoregulation in the pancreas.

    Rothe H, Ito Y, Kolb H.

    J Mol Med. 2001 May;79(4):190-7.PMID: 11409710 [PubMed - indexed for MEDLINE]Related articles

    3.

    Fas and Fas ligand immunolocalization in pancreatic islets of NOD mice during spontaneous and cyclophosphamide-accelerated diabetes.

    Redd S, Ginn S, Ross JM.

    Histochem J. 2002 Jan-Feb;34(1-2):1-12.PMID: 12365794 [PubMed - indexed for MEDLINE]Related articles

    4.

    Beta cell apoptosis in T cell-mediated autoimmune diabetes.

    Kurrer MO, Pakala SV, Hanson HL, Katz JD.

    Proc Natl Acad Sci U S A. 1997 Jan 7;94(1):213-8.PMID: 8990188 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Protection against diabetes by MHC heterozygosity and reversal by cyclophosphamide.

    Wu AY, Schulman SJ, Marconi LA, Reilly CR, Scott B, Lo D.

    Cell Immunol. 1998 Mar 15;184(2):112-20.PMID: 9630837 [PubMed - indexed for MEDLINE]Related articles

    6.

    Cellular and molecular changes accompanying the progression from insulitis to diabetes.

    André-Schmutz I, Hindelang C, Benoist C, Mathis D.

    Eur J Immunol. 1999 Jan;29(1):245-55.PMID: 9933106 [PubMed - indexed for MEDLINE]Related articles

    7.

    Dynamic interaction between T cell-mediated beta-cell damage and beta-cell repair in the run up to autoimmune diabetes of the NOD mouse.

    Vukkadapu SS, Belli JM, Ishii K, Jegga AG, Hutton JJ, Aronow BJ, Katz JD.

    Physiol Genomics. 2005 Apr 14;21(2):201-11. Epub 2005 Jan 25.PMID: 15671250 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Fas and Fas ligand immunoexpression in pancreatic islets of NOD mice during spontaneous and cyclophosphamide-accelerated diabetes.

    Reddy S, Ross JM.

    Ann N Y Acad Sci. 2003 Nov;1005:166-9.PMID: 14679052 [PubMed - indexed for MEDLINE]Related articles

    9.

    Acceleration of autoimmune diabetes by cyclophosphamide is associated with an enhanced IFN-gamma secretion pathway.

    Ablamunits V, Quintana F, Reshef T, Elias D, Cohen IR.

    J Autoimmun. 1999 Dec;13(4):383-92.PMID: 10585754 [PubMed - indexed for MEDLINE]Related articles

    11.

    Reg (regenerating) gene overexpression in islets from non-obese diabetic mice with accelerated diabetes: role of IFNbeta.

    Planas R, Alba A, Carrillo J, Puertas MC, Ampudia R, Pastor X, Okamoto H, Takasawa S, Gurr W, Pujol-Borrell R, Verdaguer J, Vives-Pi M.

    Diabetologia. 2006 Oct;49(10):2379-87. Epub 2006 Aug 10.PMID: 16900387 [PubMed - indexed for MEDLINE]Related articles

    12.

    Interferon-gamma impacts at multiple points during the progression of autoimmune diabetes.

    Wang B, André I, Gonzalez A, Katz JD, Aguet M, Benoist C, Mathis D.

    Proc Natl Acad Sci U S A. 1997 Dec 9;94(25):13844-9.PMID: 9391115 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Cyclophosphamide-induced type-1 diabetes in the NOD mouse is associated with a reduction of CD4+CD25+Foxp3+ regulatory T cells.

    Brode S, Raine T, Zaccone P, Cooke A.

    J Immunol. 2006 Nov 15;177(10):6603-12.PMID: 17082572 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Transgenic expression of decoy receptor 3 protects islets from spontaneous and chemical-induced autoimmune destruction in nonobese diabetic mice.

    Sung HH, Juang JH, Lin YC, Kuo CH, Hung JT, Chen A, Chang DM, Chang SY, Hsieh SL, Sytwu HK.

    J Exp Med. 2004 Apr 19;199(8):1143-51. Epub 2004 Apr 12.PMID: 15078896 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    CD4+CD25+ regulatory T cells control the progression from periinsulitis to destructive insulitis in murine autoimmune diabetes.

    Ott PA, Anderson MR, Tary-Lehmann M, Lehmann PV.

    Cell Immunol. 2005 May;235(1):1-11. Epub 2005 Aug 24.PMID: 16122720 [PubMed - indexed for MEDLINE]Related articles

    16.

    Early events in islets and pancreatic lymph nodes in autoimmune diabetes.

    Aspord C, Rome S, Thivolet C.

    J Autoimmun. 2004 Aug;23(1):27-35.PMID: 15236750 [PubMed - indexed for MEDLINE]Related articles

    17.

    MHC-mismatched islet allografts are vulnerable to autoimmune recognition in vivo.

    Kupfer TM, Crawford ML, Pham K, Gill RG.

    J Immunol. 2005 Aug 15;175(4):2309-16.PMID: 16081800 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Transgenic insulin (B:9-23) T-cell receptor mice develop autoimmune diabetes dependent upon RAG genotype, H-2g7 homozygosity, and insulin 2 gene knockout.

    Jasinski JM, Yu L, Nakayama M, Li MM, Lipes MA, Eisenbarth GS, Liu E.

    Diabetes. 2006 Jul;55(7):1978-84.PMID: 16804066 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    How punctual ablation of regulatory T cells unleashes an autoimmune lesion within the pancreatic islets.

    Feuerer M, Shen Y, Littman DR, Benoist C, Mathis D.

    Immunity. 2009 Oct 16;31(4):654-64. Epub 2009 Oct 8.PMID: 19818653 [PubMed - indexed for MEDLINE]Related articles

    20.

    Rotavirus infection accelerates type 1 diabetes in mice with established insulitis.

    Graham KL, Sanders N, Tan Y, Allison J, Kay TW, Coulson BS.

    J Virol. 2008 Jul;82(13):6139-49. Epub 2008 Apr 16.PMID: 18417562 [PubMed - indexed for MEDLINE]Related articlesFree article